Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
Terpos E, Mentis A, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. N Engl J Med. 2020 Oct 22;383(17):1695. doi: 10.1056/NEJMc2027051. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966711 No abstract available.
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.
Terpos E, Stellas D, Rosati M, Sergentanis TN, Hu X, Politou M, Pappa V, Ntanasis-Stathopoulos I, Karaliota S, Bear J, Donohue D, Pagoni M, Grouzi E, Korompoki E, Pavlakis GN, Felber BK, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Eur J Intern Med. 2021 Jul;89:87-96. doi: 10.1016/j.ejim.2021.05.010. Epub 2021 May 18. Eur J Intern Med. 2021. PMID: 34053848 Free PMC article. Clinical Trial.
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou ED, Bagratuni T, Liacos CI, Scorilas A, Korompoki E, Papassotiriou I, Kastritis E, Dimopoulos MA. Trougakos IP, et al. Among authors: dimopoulos ma. BMC Med. 2021 Aug 23;19(1):208. doi: 10.1186/s12916-021-02090-6. BMC Med. 2021. PMID: 34420521 Free PMC article.
Emerging antibodies for the treatment of multiple myeloma.
Zagouri F, Terpos E, Kastritis E, Dimopoulos MA. Zagouri F, et al. Among authors: dimopoulos ma. Expert Opin Emerg Drugs. 2016 Jun;21(2):225-37. doi: 10.1080/14728214.2016.1186644. Expert Opin Emerg Drugs. 2016. PMID: 27195659 Review.
Hematological findings and complications of COVID-19.
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23. Am J Hematol. 2020. PMID: 32282949 Free PMC article.
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.
Terpos E, Politou M, Sergentanis TN, Mentis A, Rosati M, Stellas D, Bear J, Hu X, Felber BK, Pappa V, Pagoni M, Grouzi E, Labropoulou S, Charitaki I, Ntanasis-Stathopoulos I, Moschandreou D, Bouhla A, Saridakis S, Korompoki E, Giatra C, Bagratuni T, Pefanis A, Papageorgiou S, Spyridonidis A, Antoniadou A, Kotanidou A, Syrigos K, Stamoulis K, Panayiotakopoulos G, Tsiodras S, Alexopoulos L, Dimopoulos MA, Pavlakis GN. Terpos E, et al. Among authors: dimopoulos ma. Microorganisms. 2020 Nov 28;8(12):1885. doi: 10.3390/microorganisms8121885. Microorganisms. 2020. PMID: 33260775 Free PMC article.
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.
Fotis C, Meimetis N, Tsolakos N, Politou M, Akinosoglou K, Pliaka V, Minia A, Terpos E, Trougakos IP, Mentis A, Marangos M, Panayiotakopoulos G, Dimopoulos MA, Gogos C, Spyridonidis A, Alexopoulos LG. Fotis C, et al. Among authors: dimopoulos ma. Sci Rep. 2021 Mar 23;11(1):6614. doi: 10.1038/s41598-021-86035-2. Sci Rep. 2021. PMID: 33758278 Free PMC article.
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
Terpos E, Trougakos IP, Apostolakou F, Charitaki I, Sklirou AD, Mavrianou N, Papanagnou ED, Liacos CI, Gumeni S, Rentziou G, Korompoki E, Papassotiriou I, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24. Am J Hematol. 2021. PMID: 33837984 Free PMC article. No abstract available.
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Terpos E, Trougakos IP, Gavriatopoulou M, Papassotiriou I, Sklirou AD, Ntanasis-Stathopoulos I, Papanagnou ED, Fotiou D, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: dimopoulos ma. Blood. 2021 Jul 1;137(26):3674-3676. doi: 10.1182/blood.2021011904. Blood. 2021. PMID: 33861315 Free PMC article. No abstract available.
1,275 results